1.Expression of NMDA Receptor Subunit mRNAs in the Developing Circadian Pacemaker of the Rat.
Hwan Tae PARK ; Seung Gu KANG ; Eun Kyoung KANG ; Ki Won BAE
Korean Journal of Anatomy 1998;31(4):595-601
Hypothalamic suprachiasmatic nucleus (SCN) is a circadian pacemaker which controls diurnal behavioral and hormonal rhythms in mammals. The SCN receives environmental light signals through the retinohypothalamic tract, and glutamate is the major excitatory neurotransmitter in the retinohypothalamic tract. In the present study, we investigated the developmental expression of the mRNAs for N-methyl-D-aspartate type glutamate receptor (NR)1, NR2A, NR2B and NR2C subunits in the rat SCN using in situ hybridization with specific riboprobes. At postnatal day 2 (P2), P8, Pl5 and P45, the high level of NRI transcripts was observed in both ventrolateral and dorsomedial subdivisions of the SCN, and the distinct expression of NR2C mRNA was principally found in the dorsomedial SCN. The weak NR2B mRNA expression was clearly found in both subdivisions of the SCN at P2 and P8, whereas specific NR2B hybridization signals were not found at Pl5 and P45. There was no specific hybridization signal of NR2A in the SCN throughout the postnatal life. These findings implicate that NR may play an important role in the neonatal SCN. In addition, this study suggests that NR1, NR2B and NR2C might be the major NR subunits in the developing SCN, whereas NRI and NR2C could be the subunit components of NR in the adult SCN.
Adult
;
Animals
;
Glutamic Acid
;
Humans
;
In Situ Hybridization
;
Mammals
;
N-Methylaspartate*
;
Neurotransmitter Agents
;
Rats*
;
Receptors, Glutamate
;
RNA, Messenger*
;
Suprachiasmatic Nucleus
2.A case of spindle cell hemangioendothelioma involving the lung, mediastinum and brain.
Hwan Tae KIM ; In Ho KIM ; Bong Choon LEE ; Chang Il KANG ; Hye Kyoung YOON
Tuberculosis and Respiratory Diseases 1993;40(3):301-307
No abstract available.
Brain*
;
Hemangioendothelioma*
;
Lung*
;
Mediastinum*
3.A case of salmonella peritonitis during continuous ambulatoryperitoneal dialysis.
You Kyoung LEE ; Tae Youn CHOI ; Won Bae KIM ; Duk Yong KANG ; Jun Hee WOO
Korean Journal of Clinical Pathology 1992;12(3):375-379
No abstract available.
Dialysis*
;
Peritonitis*
;
Salmonella*
4.A case of salmonella peritonitis during continuous ambulatoryperitoneal dialysis.
You Kyoung LEE ; Tae Youn CHOI ; Won Bae KIM ; Duk Yong KANG ; Jun Hee WOO
Korean Journal of Clinical Pathology 1992;12(3):375-379
No abstract available.
Dialysis*
;
Peritonitis*
;
Salmonella*
5.Arthroscopic scaphocapitate fusion with lunate preservation without autologous bone grafts for Lichtman stage III Kienböck disease: a retrospective observational study
Archives of hand and microsurgery 2025;30(1):43-50
Purpose:
This study aimed to evaluate the outcomes of arthroscopic scaphocapitate fusion with lunate preservation, without autologous bone grafts, in stage III Kienböck disease, which causes significant wrist dysfunction due to lunate necrosis.
Methods:
Nine patients with stage III Kienböck disease underwent arthroscopic scaphocapitate fusion with lunate preservation from 2017 to 2022. Bone substitutes were used instead of autologous bone grafts: demineralized bone matrix, allogenic cancellous bone chips, and a bone substitute composed of hydroxyapatite combined with recombinant human bone morphogenetic protein-2. The clinical outcomes assessed were pain visual analogue scale (VAS), grip strength, wrist range of motion (ROM), Patient-Rated Wrist Evaluation (PRWE), and Disabilities of the Arm, Shoulder, and Hand (DASH) scores. Radiological assessments included bone union and modified carpal height ratio (MCHR).
Results:
At a mean follow-up of 22.7 months, all patients achieved bone union, with an average time to union of 8 weeks. Significant improvements were observed in wrist ROM (mean increase from 58.3° to 75.6°, p=0.001), grip strength (29.4% to 71.8% of the contralateral side, p<0.001), DASH scores (43.9 to 17.5, p<0.001), PRWE scores (45.2 to 18.0, p<0.001), and pain VAS (5.7 to 2.9, p<0.001). The mean MCHR decreased slightly from 1.41 to 1.39 (p<0.001).
Conclusion
Arthroscopic scaphocapitate fusion with lunate preservation, without autologous bone grafts, effectively improved pain, function, and anatomical outcomes in stage III Kienböck disease. Further research is needed to validate these findings.
6.Arthroscopic scaphocapitate fusion with lunate preservation without autologous bone grafts for Lichtman stage III Kienböck disease: a retrospective observational study
Archives of hand and microsurgery 2025;30(1):43-50
Purpose:
This study aimed to evaluate the outcomes of arthroscopic scaphocapitate fusion with lunate preservation, without autologous bone grafts, in stage III Kienböck disease, which causes significant wrist dysfunction due to lunate necrosis.
Methods:
Nine patients with stage III Kienböck disease underwent arthroscopic scaphocapitate fusion with lunate preservation from 2017 to 2022. Bone substitutes were used instead of autologous bone grafts: demineralized bone matrix, allogenic cancellous bone chips, and a bone substitute composed of hydroxyapatite combined with recombinant human bone morphogenetic protein-2. The clinical outcomes assessed were pain visual analogue scale (VAS), grip strength, wrist range of motion (ROM), Patient-Rated Wrist Evaluation (PRWE), and Disabilities of the Arm, Shoulder, and Hand (DASH) scores. Radiological assessments included bone union and modified carpal height ratio (MCHR).
Results:
At a mean follow-up of 22.7 months, all patients achieved bone union, with an average time to union of 8 weeks. Significant improvements were observed in wrist ROM (mean increase from 58.3° to 75.6°, p=0.001), grip strength (29.4% to 71.8% of the contralateral side, p<0.001), DASH scores (43.9 to 17.5, p<0.001), PRWE scores (45.2 to 18.0, p<0.001), and pain VAS (5.7 to 2.9, p<0.001). The mean MCHR decreased slightly from 1.41 to 1.39 (p<0.001).
Conclusion
Arthroscopic scaphocapitate fusion with lunate preservation, without autologous bone grafts, effectively improved pain, function, and anatomical outcomes in stage III Kienböck disease. Further research is needed to validate these findings.
7.Arthroscopic scaphocapitate fusion with lunate preservation without autologous bone grafts for Lichtman stage III Kienböck disease: a retrospective observational study
Archives of hand and microsurgery 2025;30(1):43-50
Purpose:
This study aimed to evaluate the outcomes of arthroscopic scaphocapitate fusion with lunate preservation, without autologous bone grafts, in stage III Kienböck disease, which causes significant wrist dysfunction due to lunate necrosis.
Methods:
Nine patients with stage III Kienböck disease underwent arthroscopic scaphocapitate fusion with lunate preservation from 2017 to 2022. Bone substitutes were used instead of autologous bone grafts: demineralized bone matrix, allogenic cancellous bone chips, and a bone substitute composed of hydroxyapatite combined with recombinant human bone morphogenetic protein-2. The clinical outcomes assessed were pain visual analogue scale (VAS), grip strength, wrist range of motion (ROM), Patient-Rated Wrist Evaluation (PRWE), and Disabilities of the Arm, Shoulder, and Hand (DASH) scores. Radiological assessments included bone union and modified carpal height ratio (MCHR).
Results:
At a mean follow-up of 22.7 months, all patients achieved bone union, with an average time to union of 8 weeks. Significant improvements were observed in wrist ROM (mean increase from 58.3° to 75.6°, p=0.001), grip strength (29.4% to 71.8% of the contralateral side, p<0.001), DASH scores (43.9 to 17.5, p<0.001), PRWE scores (45.2 to 18.0, p<0.001), and pain VAS (5.7 to 2.9, p<0.001). The mean MCHR decreased slightly from 1.41 to 1.39 (p<0.001).
Conclusion
Arthroscopic scaphocapitate fusion with lunate preservation, without autologous bone grafts, effectively improved pain, function, and anatomical outcomes in stage III Kienböck disease. Further research is needed to validate these findings.
8.Coracoclavicular Ligament Suture Augmentation with Anatomical Locking Plate Fixation for Distal Clavicle Fracture.
Tae Kang LIM ; Min Soo SHON ; Hyung Gon RYU ; Jae Sung SEO ; Jae Hyun PARK ; Young KO ; Kyoung Hwan KOH
Clinics in Shoulder and Elbow 2014;17(4):175-180
BACKGROUND: For Neer type IIB fracture of distal clavicle with coracoclavicular ligament injury, various surgical treatments have been used in literatures. However, there was no consensus on the optimal treatment. The aim of this study is to report the clinical and radiological results of open reduction and internal fixation of unstable distal clavicle fracture and suture augmentation of disrupted coracoclavicular ligament. METHODS: A prospective study was performed in 23 patients with Neer type IIB distal clavicle fracture in Seoul Medical Center, Eulji Hospital, and National Medical Center. Firstly, suture anchors are inserted in the base of coracoid process and preliminary reduction was achieved by tie-off of three suture limbs around the clavicle. Then, the final fixation was completed with anatomical locking plate. Bony union and the distance between coracoclavicular ligaments were evaluated. Clinical results and complications including stiffness and secondary procedures were evaluated. RESULTS: Bony union was achieved in all cases except one (22 of 23). At mean 14.9 months, no significant difference in the mean coracoclavicular distance was observed compared to uninjured shoulder (8.2 +/- 7.9 mm versus 7.3 +/- 3.4 mm, p=0.14). Pain visual analogue scale, American Shoulder and Elbow Surgeons score, Constant score, and Disabilities of the Arm, Shoulder and Hand score were 0.5, 83.4, 78.5, and 6.2, respectively. Revision surgery was performed in one case of nonunion. Four patients who complained of skin irritation underwent implant removal. CONCLUSIONS: In cases of an unstable distal clavicle fracture with coracoclavicular ligament disruption, satisfactory clinical results were obtained by locking plate fixation and coracoclavicular ligament suture augmentation concurrently.
Arm
;
Clavicle*
;
Consensus
;
Elbow
;
Extremities
;
Hand
;
Humans
;
Ligaments*
;
Prospective Studies
;
Seoul
;
Shoulder
;
Shoulder Fractures
;
Skin
;
Suture Anchors
;
Sutures*
9.Carcinosarcom a of the Skin: A New Combination of Squamous Cell Carcinoma and Chondrosarcoma.
Eun Kyoung LEE ; Doo Hee YOON ; Tae Yoon KIM ; Chung Won KIM ; Hun Kyung LEE ; Seok Jin KANG
Annals of Dermatology 1998;10(2):81-85
Carcinosarcoma is a rare malignant tumor composed of a mixture of neoplastic epithelial and mesenchymal elements, which has been reported in many organ systems, but its occurrence is very rare in the skin. An 81-year-old female patient presented with aml-year-history of a painful exophytic mass on the tip of the middle finger of the right hand involving the distal part of the nail bed. The mass was 1 × 1 × 0.6 cm in size, hard, flesh colored, ulcerated and easily bleeding. Microscopically, the epidermis at the margin of the tumor showed the characteristic findings of squamous cell carcinoma and the carcinomatous component was mixed with malignant mesenchymal components focally differentiating into chondrosarcoma. This combination of squamous cell carcinoma and chondrosarcoma has not been reported yet in the skin. She had a distal interphalanx amputation and no recurrence appeared for 1 year on follow-up.
Aged, 80 and over
;
Amputation
;
Carcinoma, Squamous Cell*
;
Carcinosarcoma
;
Chondrosarcoma*
;
Epidermis
;
Epithelial Cells*
;
Female
;
Fingers
;
Follow-Up Studies
;
Hand
;
Hemorrhage
;
Humans
;
Recurrence
;
Skin*
;
Ulcer
10.A study on recognition of ABO and Rh blood phenotype in blood donors.
Tae Youn CHOI ; Jung Myeong LEE ; You Kyoung LEE ; Won Bae KIM ; Duk Yong KANG ; Young Chul OH
Korean Journal of Blood Transfusion 1993;4(1):29-34
No abstract available.
Blood Donors*
;
Humans
;
Phenotype*